Ramosetron for the treatment of irritable bowel syndrome with diarrhea: A systematic review and meta-analysis of randomized controlled trials
BMC Gastroenterology | Jan 13, 2018
Qi Q, et al. - Researchers performed this systematic review to examine the efficacy and safety of ramosetron for irritable bowel syndrome with diarrhea (IBS-D). Among both male and female IBS-D patients, ramosetron had beneficial effects. More hard stool and constipation could be noted with ramosetron treatment, without severe adverse events.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries